- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Acorda Therapeutics Inc+ Add to Watchlist
ACOR:US32.0800 USD 0.3200 0.99%
As of 20:10:00 ET on 05/22/2013.
Company Profile for Acorda Therapeutics Inc (ACOR)
Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.
Acorda Therapeutics Inc
Key Executives for Acorda Therapeutics Inc (ACOR)
|Ron CohenPresident/CEO/Founder||David LawrenceChief Financial Officer|
|Enrique J CarrazanaChief Medical Officer||Andrew R Blight "Andy"Chief Scientific Officer|
|Jane WasmanPres:Intl/Secy/Gen Cnsl||Lauren M SabellaExec VP:Commercial Dev|